Filing Flows › Veracyte (VCYT) › Gross margin
Veracyte (VCYT) gross margin by quarter
Veracyte's gross margin was 70.6% in Q3 2026 (third quarter 2026), -1.6 pts from Q2 2026. Over the last 6 quarters it ranged from 69.2% (Q3 2025) to 72.7% (Q1 2026).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 70.6% | -1.6 pts | +1.4 pts |
| Q2 2026 | 72.2% | -0.5 pts | — |
| Q1 2026 | 72.7% | +0.2 pts | +3.3 pts |
| Q4 2025 | 72.5% | +3.3 pts | — |
| Q3 2025 | 69.2% | -0.2 pts | — |
| Q1 2025 | 69.5% | — | — |
Q3 2026 at a glance
Veracyte, Q3 2026: revenue $152M (+15% year over year), operating margin 10.9%, net earnings $31.5M, operating cash flow $40.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Veracyte's gross margin?
Veracyte's gross margin was 70.6% in Q3 2026 (third quarter 2026), -1.6 pts from Q2 2026.
How has Veracyte's gross margin changed?
Over the last 6 quarters it ranged from 69.2% (Q3 2025) to 72.7% (Q1 2026).